Titan Pharmaceuticals
TTNP
#10405
Rank
โ‚น0.54 B
Marketcap
โ‚น412.67
Share price
-3.76%
Change (1 day)
40.45%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -โ‚น369.19

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น392.98. In 2023 the company made an earnings per share (EPS) of -โ‚น663.32 an increase over its 2022 EPS that were of -โ‚น1,360.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น369.19
2023-โ‚น663.32-51.22%
2022-โ‚น1,360-15.61%
2021-โ‚น1,611-81.37%
2020-โ‚น8,647-77.52%
2019-โ‚น38,474-56.32%
2018-โ‚น88,086-59.51%
2017-โ‚น2,17,572-371.81%
2016โ‚น80,045-144.35%
2015-โ‚น1,80,468300%
2014-โ‚น45,117-121.54%
2013โ‚น2,09,471-151.38%
2012-โ‚น4,07,664-11.54%
2011-โ‚น4,60,838188.89%
2010-โ‚น1,59,521-10%
2009-โ‚น1,77,245
2007-โ‚น7,26,706-2.38%
2006-โ‚น7,44,430-39.13%
2005-โ‚น12,22,992-16.87%
2004-โ‚น14,71,136-22.43%
2003-โ‚น18,96,5244.9%
2002-โ‚น18,07,90261.9%
2001-โ‚น11,16,645-13.7%
2000-โ‚น12,93,89065.01%
1999-โ‚น7,84,141-35.87%
1998-โ‚น12,22,784-1824.71%
1997โ‚น70,898-102.4%
1996-โ‚น29,59,996

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Vanda Pharmaceuticals
VNDA
-โ‚น127.11-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น22.38-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น302.57-23.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น934.50-337.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น658.85-267.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Repligen
RGEN
โ‚น2.69-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA